Abilitech Medical | Angie Conley, CEO

(Transcription)

Angie Conley  0:00  

All right, Happy Friday, everybody. Thank you for coming. I Angie Conley, we are addressing an important problem. There are over 1 million people in the United States who have weak or injured arms and they can't use them. Think about this conference and what it would be like to not shake somebody's hand or feed yourself, or even push an elevator button to open a door. That's the problem we're solving. And it's significant. Here's a short video that I'll show and it describes how we solve the problem from a patient, clinician and caregiver perspective.

Video playing  0:55  

My name is Luanne would lick and I'm Rob's Mom, we're one of those families that got the terrible phone call. He had them dove in to the river, he was paralyzed at that point.

My name is Jimmy Nelson, I'm a nurse and also a caretaker. So as a personal care assistant, I do see the first hand effects that stem from both physical limitation and constant dependence.

In our field, there is a lack of devices that can treat the upper extremity in a way that allows it to be independent for longer with less use of energy.

Fortunately, we do have a device to the bill tech assist, that would facilitate more independence. 

When he put the put the arm on, he just touched his face and his eyes just lit up.

One thing I like about the ability tech, assistive technology is that it's very simple. You just have to think about moving your arm, the assistant, the shoulder allows you to get that hand where you need it to be to actually engage in your environment. A lot more.

Patients having the device they get to be more independent, they get to eat by themselves, they get to talk on the phone independently. They get to fill their own medications are so they can rejoin their community they can go to school, they can maybe go to work.

Simple things on a daily basis truly like being able to drink out of a glass feeding himself. That is a huge, huge thing for us

The drive of our CEO Angie Connolly and our entire team, we're developing a device that really is going to change lives. 

Our technology will benefit muscular dystrophy, spinal cord,

MS, central cord syndrome and brachial plexus and someday stroke. One thing I like about the ability tech assistive technology is that it allows them to do things for themselves for longer periods of time. It really decreases that amount of burden where somebody else is always there having to help them lift move, feed that also allows rehabilitation therapists to work with patients to do more to train more as we do things with more repetition, more frequency, it retrains our mind that retrains our muscles and oftentimes we can feign function.

I believe that the Abilitech System definitely has the power to give someone their independence back. I mean, how amazing is that?

Angie Conley  3:18  

How amazing is that? We can demonstrate efficacy and the very first fitting and help people do needed activities of daily living. I've created a team of me with experience of over 200 years of medical device experience with three different accents. We have some of Minnesota's best and brightest. My background is at Medtronic where I was a senior product manager on three different product lines. And we have a deep and talented workforce there. This is Mr. Cut, he is a veteran. And we were able to help him eat and drink and turn pages of a book. But he also reports having less pain in his shoulder, which is really quite significant because he only took three of his 31 pain pills last month. So hopefully I've convinced you that it is an awesome social impact. But this is a massive financial opportunity. And this year our beachhead market is spinal cord injury. And we are studying we are a 510 K class one exempt or 510 K exempt class one med device. And so we got to market we can help people and now we're building outcomes, patient outcomes, publishing stories, getting relationships in to the field getting sales revenue, and payer contracts. This all provides a foundation for when we launch our next gen device that will scale in late 2025 reimbursement strategy has been informed and directed by some of the industry's brightest, the VP of autobox reimbursement lives in Minnesota. I've worked with OSA miombo and several others to lay out a strategy that has even directed the design the channel and everything about our device. So that we will submit for a brand new code in 2024 that will support the launch of our next gen device. This is Abilitech solution, you put it on your, on your on your body with a vest you It clips in, and right now we help people who are using a wheelchair. Some people call it the power steering for the arms. And others report that they're in a pool and their arms are floating because of the gravity balance mechanism that we use. We have motors that tension the springs to be able to provide three levels of assistance that you might need for a spoon, a cellphone or a 12 ounce glass of water. This is Rob, Rob lives with a neck level injury. He's a quadriplegic lives with his 72 year old mom and WISE data. And he dove in at in the Grand Canyon after a piece of trash and left in a helicopter. He's lifting a 2.4 ounce granola bar. This is without our device and with our device. And then we put in an eight ounce water bottle, something we all take for granted without our device and with our device. Meet Gloria, Gloria lives with a spinal cord injury and he's also had a stroke in Austin, Texas. This is her ability without our device. And then her rehab center posted this on Instagram last month and we were thrilled to see them integrating it in so that she can help better navigate her daily space. GLORIA uses our device every day. This is a man with a stroke in California. There's no video but what he or audio but what he's saying is, this is the first time I've been able to use and eat a granola bar in 10 years since my stroke. So we have we're a first in class device. We have amazing clinical support. And the good thing is everybody has helped us. We have amazing clinical support. We've done feasibility studies funded by NIH grants and of spinal cord injury and of cerebral palsy at Texas Children's, the largest children's hospital in the world. This year, we are doing a muscular dystrophy study at Gillette Children's in the University of Minnesota, two of the largest worldwide muscular dystrophy clinics. And then we'll continue doing studies in spinal cord injury and looking at feasibility studies for stroke. Our freedom we have a freedom to operate in a robust patent portfolio. This is the cyst it comes in a large, medium and now small right and left and it meets a wheelchair population. Our next generation device will be for walking patients like brachial plexus or stroke. And I'm raising $12 million. I raised 15 million to date this $12 million will help us generate the needed patient outcomes and published studies and validate our reimbursement and everything that will need the foundation to scale our next gen device and the development of the next gen device. And with that my name is Angie several kindly I thank you for your time on this Friday afternoon and I would welcome your questions afterwards. Thank you